Oramed Pharmaceuticals Inc.

ORMPNASDAQUSD
4.11 USD
0.04 (0.95%)🟢PRE MARKET (AS OF 04:08 AM EDT)
🟢Market: OPEN
Open?$4.16
High?$4.16
Low?$4.07
Prev. Close?$4.11
Volume?24
Avg. Volume?112.8K
VWAP?$4.16
Rel. Volume?0.00x
Bid / Ask
Bid?$3.54 × 100
Ask?$4.68 × 100
Spread?$1.14
Midpoint?$4.11
Valuation & Ratios
Market Cap?166.2M
Shares Out?40.4M
Float?32.3M
Float %?81.2%
P/E Ratio?2.63
P/B Ratio?0.83
EPS?$1.56
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.98Strong
Quick Ratio?6.98Strong
Cash Ratio?2.41Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
73/100
P/E?
2.6CHEAP
P/B?
0.83CHEAP
P/S?
83.12HIGH
P/FCF?
N/A
EV/EBITDA?
-8.1CHEAP
EV/Sales?
60.47HIGH
Returns & Efficiency
ROE?
31.7%STRONG
ROA?
27.4%STRONG
Cash Flow & Enterprise
FCF?$-74116000
Enterprise Value?$120.9M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
Employees
13
Market Cap
155.7M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2004-04-19
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK, NY 10036
Phone: 646-844-1164